Dry ice

Thermal Custom Packaging Fights the Supply Chain Crisis with Totes and Phase Change Materials.

Retrieved on: 
Wednesday, August 17, 2022
Carbon, GLOBE, Tote, Refrigeration, Law enforcement, PCM, COVID-19, Food, Vaccine, Dry ice, Transport, TCP, PCM, Inc., Solution, Time, Medicine, Longevity, RNA transfection, Temperature, Warehouse

can be transported and stored for extended periods of time using TCPs totes and Phase Change Materials (PCMs).

Key Points: 
  • can be transported and stored for extended periods of time using TCPs totes and Phase Change Materials (PCMs).
  • As this crisis continues to wreak havoc on the world, TCP is providing solutions.
  • TCP totes are quality insulated containers that keep sensitive materials at desired temperatures using custom-made TCP PCMs.
  • Thermal Custom Packaging (TCP) is a product manufacturer specializing in cold-chain transport solutions, insulated containers (totes), and the chemical reactions that maintain them.

FuelCell Energy Launches New Carbon Savings Calculator

Retrieved on: 
Thursday, August 4, 2022
Carbon, Urbanization, Refrigeration, PH, Water, Quality of life, Plastic, Food, B cell, Energy drink, Water purification, FuelCell Energy, Compliance, Carbon dioxide, Dry ice, Food security, Nasdaq, Safety, CO2, Drinking water, Time, Solution, Hydrogen, GLOBE, Hospital, Â, Risk, NASDAQ, Renewable energy, Recycling, Bottled water

DANBURY, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. , (Nasdaq: FCEL) -- a global leader in manufacturing stationary fuel cell energy platforms for decarbonizing power, and producing hydrogen to enable a world empowered by clean energy today announced a new Carbon Savings Calculator for companies looking to gain greater insight into how the carbon dioxide (CO2) produced by their operation across Scope 1 and Scope 2 emissions can be recycled and used in their business.

Key Points: 
  • DANBURY, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. , (Nasdaq: FCEL) -- a global leader in manufacturing stationary fuel cell energy platforms for decarbonizing power, and producing hydrogen to enable a world empowered by clean energy today announced a new Carbon Savings Calculator for companies looking to gain greater insight into how the carbon dioxide (CO2) produced by their operation across Scope 1 and Scope 2 emissions can be recycled and used in their business.
  • FuelCell Energy presents a compelling opportunity for manufacturers, food processors, hospitals, and a broad range of commercial and industrial customers to recycle CO2.
  • Working with FuelCell Energy to upcycle CO2 for food and beverage applications could provide dramatic benefits like cost savings, independence from traditional sources, and availability.
  • FuelCell Energy, Inc. (NASDAQ: FCEL): FuelCell Energy is a global leader in sustainable clean energy technologies that address some of the worlds most critical challenges around energy, safety and global urbanization.

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

Retrieved on: 
Tuesday, July 26, 2022
Biotechnology, Neurology, Surgery, Medical Devices, Health, Dry ice, Surgeon, Carbon, Insurance, Hospital, Deutsches Institut für Bautechnik, Advanced Therapy Medicinal Product, SEC, Temperature, Risk, Partnership, Hand, Securities Act of 1933, Securities Exchange Act of 1934, International Institute of Refrigeration, Multimedia, NASDAQ, Trinity, Ministry of Education (Malaysia), German Institute for Medical Documentation and Information, Organization, Cell, Spine, Technology, Company, Biologic, MTF, Science, Patient, Efficiency, Baylor Scott & White Medical Center – Temple, Overalls, Terminology, Annual report, Elective surgery, Drug Quality and Security Act, Communication, Medical device, Pharmaceutical industry, Virtuos

(NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures.

Key Points: 
  • (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures.
  • View the full release here: https://www.businesswire.com/news/home/20220726005177/en/
    Virtuos Lyograft is a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures in a room-temperature, ready-to-use, moldable form.
  • This helps ensure we can always have an easy-to-use, moldable, complete bone graft on hand, and it streamlines the preparation and overall surgical procedure time.
  • The Virtuos Lyograft provided through our exclusive partnership with MTF Biologics is at the forefront of allograft technology, said Orthofix President of Global Spine Kevin Kenny.

Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center

Retrieved on: 
Monday, July 18, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Clinical trial, Dry ice, CEO, Patient, LinkedIn, Hospital, LH, NYSE, Kidney disease, Collection, Drug development, Multimedia, EMEA, Diabetes, Health, Pharmaceutical industry, LabCorp

Labcorp (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium.

Key Points: 
  • Labcorp (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium.
  • Once completed, expansion will allow for clinical trial test kits to be fulfilled in Mechelen for more than 70 countries throughout Europe, the Middle East and Africa (EMEA).
  • The expanded, automated line is housed in Labcorp Drug Developments European Operations Center, a multi-use facility responsible for kit production as well as study logistics and support and dry ice production and distribution.
  • The European Operations Center expands Labcorp Central Laboratory Services capacity and supports future business growth for the enterprise.

LabConnect, Inc. Announces Expansion of its Operations in Europe with Acquisition of Cryo Store B.V. and the Appointment of Marc van Kempen as General Manager Europe

Retrieved on: 
Tuesday, July 5, 2022
MSD, Acquisition, Teva Pharmaceuticals, Business, Biotechnology, General officer, Industry, Commercial, Dry ice, General manager, GDP, Temperature, Multimedia, Fine chemical, Joure

Cryo Store provides a full range of temperature controlled biostorage, supply, and logistics services to the pharmaceutical, biotechnology, and health care industries.

Key Points: 
  • Cryo Store provides a full range of temperature controlled biostorage, supply, and logistics services to the pharmaceutical, biotechnology, and health care industries.
  • In addition to the acquisition of Cryo Store, LabConnect is pleased to announce the appointment of Marc van Kempen as General Manager Europe.
  • Founded in 1999 Cryo Store is ISO 9001 certified and holds a GDP compliant wholesale distribution license.
  • Cryo Store has developed a full range of validated shippers and offers dry ice provisioning combined with logistics track and trace services.

LabConnect, Inc. Announces Expansion of its Operations in Europe with Acquisition of Cryo Store B.V. and the Appointment of Marc van Kempen as General Manager Europe

Retrieved on: 
Tuesday, July 5, 2022
MSD, Acquisition, Teva Pharmaceuticals, Business, Biotechnology, General officer, Industry, Commercial, Dry ice, General manager, GDP, Temperature, Fine chemical, Joure

Cryo Store provides a full range of temperature controlled biostorage, supply, and logistics services to the pharmaceutical, biotechnology, and health care industries.

Key Points: 
  • Cryo Store provides a full range of temperature controlled biostorage, supply, and logistics services to the pharmaceutical, biotechnology, and health care industries.
  • In addition to the acquisition of Cryo Store, LabConnect is pleased to announce the appointment of Marc van Kempen as General Manager Europe.
  • Founded in 1999 Cryo Store is ISO 9001 certified and holds a GDP compliant wholesale distribution license.
  • Cryo Store has developed a full range of validated shippers and offers dry ice provisioning combined with logistics track and trace services.

Harris Williams Advises Cold Jet on Its Minority Investment From Seidler Equity Partners and Stonehenge Partners

Retrieved on: 
Tuesday, June 14, 2022
Other Professional Services, Other Manufacturing, Finance, Packaging, Banking, Chemicals, Plastics, Professional Services, Manufacturing, Financial Conduct Authority, Seidler, Eye, Manufacturing, Gene, Harris Williams & Co., Company, Wanhua Industrial Group, SIPC, HRB, Solution, Registrar, VAT-free imports from the Channel Islands, Growth, Farringdon Road, Health, NYSE, Dry ice, PNC, Broker-dealer, CO2, Financial system, FINRA, View, Safety, Security (finance)

Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised Cold Jet, a global leader in innovative dry ice technologies, on its minority investment from Seidler Equity Partners (Seidler) and Stonehenge Partners (Stonehenge).

Key Points: 
  • Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised Cold Jet, a global leader in innovative dry ice technologies, on its minority investment from Seidler Equity Partners (Seidler) and Stonehenge Partners (Stonehenge).
  • The transaction was led by John Arendale , Chuck Walter and Tom Dunne of the Harris Williams Industrials Group .
  • As a leader in dry ice technology, Cold Jet is recognized for its innovative solutions, best-in-class equipment, and top-notch customer services, said John Arendale, a managing director at Harris Williams.
  • Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

Cold Jet, Seidler Equity Partners and Stonehenge Partners Transact Minority Investment Partnership in Collaboration with Harris Williams M&A Advisory Services

Retrieved on: 
Tuesday, June 14, 2022
Seidler, Dry ice, Global health, ESG, CEO, Partnership, Multimedia, Chengdu Aircraft Industry Group, Pleasure, Health, NYSE, COVID-19, PNC, Industry, Harris Williams & Co., CO2, Financial system, View, Safety, Airline, Food preservation

"Cold Jet invented modern dry ice technology," said Gene Cooke III, President & CEO, at Cold Jet.

Key Points: 
  • "Cold Jet invented modern dry ice technology," said Gene Cooke III, President & CEO, at Cold Jet.
  • "Our sole focus for 30+ years has been on developing and innovating the most technologically advanced dry ice solutions available.
  • The company provides flexible capital that meets the needs of all stakeholders including majority equity, minority equity, debt, and combinations thereof.
  • Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust.

GenTegra Expands Nucleic Acid Sample Stabilization Product Portfolio to Include RNA in Fresh Tissues

Retrieved on: 
Tuesday, June 14, 2022
Biotechnology, Medical Devices, Other Health, Health, Pharmaceutical, Collection, RNA, RNA-Seq, Technology, DNA, Research, Dry ice, ACP, Infection, Solution, Temperature, Vaccine

GenTegra LLC , an innovator of complete sample protection for biological research, announced today the launch of RNAdvantage , the latest addition to their suite of RNA stabilization products.

Key Points: 
  • GenTegra LLC , an innovator of complete sample protection for biological research, announced today the launch of RNAdvantage , the latest addition to their suite of RNA stabilization products.
  • With the launch of RNAdvantage, GenTegra products now stabilize and protect valuable RNA in fresh tissue samples, purified liquid RNA using RNAssure , and ambient shipping and long-term storage with GenTegraRNA .
  • GenTegra has developed a comprehensive portfolio of nucleic acid stabilization products utilizing our patented Active Chemical Protection (ACP) technology.
  • This latest addition to GenTegras product portfolio addresses an important segment of the rapidly growing RNA market, the need to preserve the integrity of RNA in fresh tissue samples.

BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services

Retrieved on: 
Thursday, June 9, 2022
Transport, Temperature, BLFS, Forward-looking statement, CEO, CGT, Hope, CDMO, Private Securities Litigation Reform Act, Risk, Dry ice, Solution, NASDAQ, Judgement, SEC, Twitter, Clinical trial, ULT, Baxter International, Terminology, Running, Fine chemical

BOTHELL, Wash., June 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that its SciSafe® biostorage services platform will now offer a fleet of refrigerated and ultra-low temperature ("ULT") truck trailers to manage local cold chain movements for customers' biologic materials.  This fleet provides an ideal transportation solution for any biologic product movement requiring ULT storage between -20°C and -196°C without the added need for dry ice as it moves from pharmaceutical manufacturer to contract development and manufacturing company ("CDMO") sites and can be deployed worldwide.  Running on generator power with two cooling systems, the fleet can also carry up to ten plugged in, powered, and running upright ULT freezers at a time, expanding supported temperatures to as low as -86°C with equipment to track location and trailer temperatures, in real time. The controlled temperature trailers can also transport liquid nitrogen storage freezers containing biologic materials stored at -150°C and colder.

Key Points: 
  • The controlled temperature trailers can also transport liquid nitrogen storage freezers containing biologic materials stored at -150C and colder.
  • This new domestic transport service enables operational flexibility and reduced risk through the same provider SciSafe customers already trust with their sample management.
  • These controlled temperature trailers expand the volume as well as the type of materials that can be moved and, in turn, increase the value we can offer our customers."
  • BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets.